Northwestern Mutual Wealth Management
AXSM icon

Northwestern Mutual Wealth Management’s Axsome Therapeutics AXSM Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$65.4K Buy
387
+17
+5% +$2.94K ﹤0.01% 2342
2025
Q4 		$67.6K Sell
370
-102
-22% -$14.2K ﹤0.01% 2286
2025
Q3 		$57.3K Buy
472
+66
+16% +$7.43K ﹤0.01% 2270
2025
Q2 		$42.4K Buy
406
+24
+6% +$2.54K ﹤0.01% 2320
2025
Q1 		$44.6K Hold
382
– – ﹤0.01% 2218
2024
Q4 		$32.3K Buy
382
+37
+11% +$3.4K ﹤0.01% 2342
2024
Q3 		$31K Buy
345
+10
+3% +$873 ﹤0.01% 2326
2024
Q2 		$27K Buy
+335
New +$24.8K ﹤0.01% 2305

Other funds holding AXSM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northwestern Mutual Wealth Management's AXSM Position: Q1 2026 in Review

Northwestern Mutual Wealth Management increased its Axsome Therapeutics (AXSM) stake by 4.6% in Q1 2026, buying an estimated $2.94K and bringing the position to 387 shares worth $65.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2342.

Northwestern Mutual Wealth Management first reported a position in AXSM in Q2 2024 and has held it in 8 quarters since. The position peaked at $67.6K in Q4 2025. 409 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.

  • Northwestern Mutual Wealth Management held 387 shares of Axsome Therapeutics worth $65.4K as of Q1 2026.
  • Northwestern Mutual Wealth Management bought 17 Axsome Therapeutics shares in Q1 2026, an estimated $2.94K.
  • Axsome Therapeutics made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q1 2026, its #2342 holding.
  • Northwestern Mutual Wealth Management first reported a position in Axsome Therapeutics in Q2 2024 and has held it in 8 quarters since.
  • Northwestern Mutual Wealth Management's Axsome Therapeutics position peaked at $67.6K in Q4 2025.
  • 409 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.